BDX is down 1.27% today. Volume is 1.64M vs a 30-day average of 1.70M (0.96x).
Becton, Dickinson and Company is scheduled to report earnings Thu, Nov 5, 2026 · after close. Analysts expect EPS of $4.11 on revenue of about $5.16B. Stocks often move sharply on earnings day.
Becton Dickinson has delivered a strong share price run over the past year, which puts fresh focus on whether the current US$200.42 level is grounded in the cash it can generate. …
Becton Dickinson (BDX) heads into its fourth quarter fiscal 2026 report with investors focused on recent execution improvements, progress in higher growth businesses, fresh produc…
BD's 25.5% rally reflects stronger execution, portfolio reshaping, product innovation and U.S. manufacturing investments despite tariffs and cost pressures.
Investors hold Becton Dickinson (BDX) and Boston Scientific (BSX) for newer products that grow faster than the rest of their sales. Becton Dickinson sells everyday hospital suppli…
Becton, Dickinson and Company stock surged 26% in 4 months as fundamentals rebounded; now near fair value at 15x P/E, rated HOLD. Click for more on BDX stock.